Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03635645 · ClinicalTrials.gov registry record · NA

Experimental and Clinical Studies of Retinal Stimulation

A NA study of Retinitis Pigmentosa, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03635645 is a NA study of Retinitis Pigmentosa that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 20 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03635645, a NA study of Retinitis Pigmentosa, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.

Conditions Studied

Interventions

  • DEVICE New visual processing unit (VPU) with asymmetric waveforms
  • DEVICE New VPU with bipolar stimulation

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-10-30
Est. Completion 2023-10-30
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03635645

The ClinicalTrials.gov registry entry for NCT03635645 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 2 interventions - of which New visual processing unit (VPU) with asymmetric waveforms is the first listed.

NCT03635645 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03635645 about?

NCT03635645 is a clinical study titled "Experimental and Clinical Studies of Retinal Stimulation". The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.

What is the current status of trial NCT03635645?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2017-10-30. Estimated completion is 2023-10-30.

What conditions does trial NCT03635645 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT03635645?

The interventions under investigation include: New visual processing unit (VPU) with asymmetric waveforms (DEVICE), New VPU with bipolar stimulation (DEVICE).

Who is sponsoring clinical trial NCT03635645?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03635645 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.